[{"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-001", "question": "A 14-year-old boy with a history of recurrent epistaxis presents with progressive dyspnea and hemoptysis. Physical examination reveals telangiectasias on the lips and oral mucosa. Pulmonary angiography shows multiple arteriovenous malformations. Genetic testing confirms a mutation in the ENG gene. What is the most appropriate long-term management strategy to prevent recurrent pulmonary complications?", "options": ["Prophylactic coil embolization of all visible AVMs", "Lifelong anticoagulation with warfarin", "Serial transcatheter embolotherapy guided by symptom recurrence", "Surgical lobectomy for affected lung segments", "Observation with annual CT angiography"], "answer": "C", "answer_index": 2, "explanation": "In hereditary hemorrhagic telangiectasia (HHT) due to ENG mutation, pulmonary AVMs are managed with transcatheter embolotherapy, repeated as needed based on symptoms or imaging, as complete eradication is often not feasible and new AVMs can develop. Prophylactic embolization of all AVMs risks unnecessary procedures and complications, while anticoagulation increases bleeding risk without addressing AVMs. Surgical options are reserved for cases unresponsive to embolization.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "This patient presents with signs and symptoms of Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome. The diagnosis is supported by the recurrent epistaxis, mucocutaneous telangiectasias, pulmonary arteriovenous malformations (PAVMs), and the confirmed ENG gene mutation (associated with HHT type 1).\n\nPulmonary arteriovenous malformations (PAVMs) create a right-to-left shunt, bypassing the pulmonary capillary filter. This leads to two main categories of complications:\n1.  Hypoxemia (causing dyspnea).\n2.  Paradoxical embolization, allowing clots or bacteria to reach the systemic circulation, leading to stroke or brain abscess.\n3.  Hemorrhage (hemoptysis, hemothorax).\n\nThe question asks for the most appropriate long-term management strategy.\n\n*   Option A: Prophylactic coil embolization of all visible AVMs.\n    Transcatheter embolotherapy is the standard of care for the treatment of PAVMs. The goal is to occlude the feeding arteries to the AVMs. Historically, treatment was recommended for feeding arteries $\\ge 3$ mm, but current guidelines and practice advocate for treating all technically feasible PAVMs (often those visible on angiography) to minimize the risk of paradoxical embolization (stroke/abscess) and improve oxygenation. In a symptomatic patient (dyspnea, hemoptysis), treatment is indicated regardless of strict size criteria if feasible. This prevents the complications associated with the shunt.\n\n*   Option B: Lifelong anticoagulation with warfarin.\n    Anticoagulation is generally contraindicated or used with extreme caution in HHT patients due to the high risk of severe recurrent epistaxis and gastrointestinal bleeding from telangiectasias. Furthermore, the primary mechanism of stroke in PAVM is the passage of venous thrombi through the shunt; the definitive treatment is closing the shunt (embolization), not lifelong anticoagulation.\n\n*   Option C: Serial transcatheter embolotherapy guided by symptom recurrence.\n    While serial follow-up is necessary (as PAVMs can recanalize or new ones can grow), management is guided by imaging (CT angiography) rather than symptom recurrence. Waiting for symptoms (e.g., stroke, brain abscess, massive hemoptysis) to recur before intervening is dangerous and represents a failure of prophylaxis. Asymptomatic PAVMs usually require treatment if they meet anatomical criteria to prevent these catastrophic events.\n\n*   Option D: Surgical lobectomy for affected lung segments.\n    Surgery (lobectomy or wedge resection) is reserved for complications not manageable by embolization or for complex AVMs that fail localized therapy. It is too invasive as a first-line strategy, particularly because PAVMs in HHT are often multiple and bilateral, and preserving lung parenchyma is essential.\n\n*   Option E: Observation with annual CT angiography.\n    Observation is inappropriate for a patient with symptomatic PAVMs (dyspnea, hemoptysis). Even in asymptomatic patients, PAVMs with feeding arteries usually $\\ge 3$ mm are treated to prevent complications. Leaving the shunts patent poses a significant risk of brain abscess and stroke.\n\nTherefore, transcatheter embolization is the correct treatment.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-002", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "source_question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed123.jsonl", "pred": "D", "model_outputs": "Here is the step-by-step reasoning for the correct answer:\n\n1.  Patient Status: The patient is presenting with hypotension and tachycardia following a motor vehicle collision, which indicates hemodynamic instability (likely Class III or IV hemorrhagic shock).\n2.  Initial Management: Due to the positive FAST exam and hemodynamic instability, the patient is correctly taken immediately for an exploratory laparotomy.\n3.  Intraoperative Decision Making: The primary goal in a hemodynamically unstable trauma patient is immediate control of hemorrhage to prevent the lethal triad of acidosis, hypothermia, and coagulopathy.\n4.  Evaluating Options:\n    *   A. Splenic artery embolization: This is typically performed in Interventional Radiology for hemodynamically *stable* patients with high-grade injuries or active extravasation seen on CT. It is not the standard intraoperative management during a laparotomy for an unstable patient.\n    *   B & C. Partial splenectomy / Splenorrhaphy: While spleen-preserving surgery is ideal to maintain immune function, it is time-consuming and technically demanding. In a hemodynamically unstable patient, prolonged surgical time increases the risk of mortality. These options are reserved for stable patients with amenable injuries.\n    *   E. Non-operative management: This is the standard of care for *hemodynamically stable* patients. It is contraindicated in patients with peritonitis or hemodynamic instability.\n    *   D. Total splenectomy: This is the definitive and most rapid method to stop bleeding from the spleen. In the setting of hemodynamic instability, \"damage control\" principles apply, and preserving the organ is secondary to preserving the patient's life.\n\nTherefore, total splenectomy is the most appropriate management to achieve rapid hemostasis in this unstable patient.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-003", "question": "A 32-year-old woman at 28 weeks gestation with a history of antiphospholipid syndrome presents with severe preeclampsia. Laboratory evaluation shows thrombocytopenia, elevated liver enzymes, and hemolysis. Fetal monitoring indicates non-reassuring heart rate patterns. What is the most appropriate immediate management?", "options": ["Expectant management with close monitoring", "Immediate delivery via cesarean section", "Administration of intravenous magnesium sulfate alone", "Plasma exchange therapy", "High-dose corticosteroid initiation"], "answer": "B", "answer_index": 1, "explanation": "In HELLP syndrome superimposed on preeclampsia in antiphospholipid syndrome, immediate delivery is indicated at 28 weeks due to maternal and fetal risks. Expectant management is not suitable beyond 34 weeks or with severe features; magnesium prevents seizures but does not address the need for delivery. Plasma exchange and steroids are not first-line.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "target_topic", "source_label_raw": "Obstetrics and Gynecology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "B", "model_outputs": "Here is the step-by-step assessment of the clinical scenario:\n\n1.  Diagnosis: The patient presents with hemolysis, elevated liver enzymes, and low platelets (thrombocytopenia). This triad is diagnostic of HELLP syndrome, a severe form of preeclampsia.\n2.  Fetal Status: The problem states there are \"non-reassuring heart rate patterns.\" This indicates fetal distress, suggesting the fetus is currently hypoxic or acidotic and may suffer permanent injury or death if not delivered rapidly.\n3.  Management Principles:\n    *   The definitive treatment for HELLP syndrome is delivery of the fetus and placenta.\n    *   At 28 weeks, expectant management (Option A) to gain fetal maturity is usually only considered if the maternal and fetal conditions are stable. Since there is fetal distress and severe maternal disease, expectant management is contraindicated.\n    *   While Magnesium sulfate (Option C) is indicated for seizure prophylaxis in this patient, it is not the *sole* management and does not resolve the fetal distress or the underlying pathology of HELLP syndrome requiring delivery.\n    *   Corticosteroids (Option E) are typically administered for fetal lung maturity if delivery can be safely delayed for 24-48 hours. However, with a non-reassuring fetal heart rate, there is no time to wait for the steroid effect.\n    *   Plasma exchange (Option D) is generally reserved for atypical cases or thrombotic thrombocytopenic purpura (TTP), not typical HELLP syndrome requiring obstetric intervention.\n4.  Conclusion: The combination of severe maternal disease (HELLP) and fetal distress (non-reassuring heart rate) mandates immediate delivery. A cesarean section is the most appropriate route to expedite delivery in the setting of fetal distress where vaginal delivery is not imminent.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-004", "question": "A 55-year-old man undergoing coronary artery bypass grafting develops refractory hypotension post-cardiopulmonary bypass. Echocardiography shows right ventricular dilation and septal shift. Pulmonary artery catheter reveals elevated pulmonary artery pressures. What is the most appropriate pharmacologic intervention?", "options": ["Inhaled nitric oxide", "Intravenous dobutamine", "Milrinone infusion", "Norepinephrine bolus", "Vasopressin drip"], "answer": "A", "answer_index": 0, "explanation": "Prototypical right ventricular failure post-CABG with pulmonary hypertension responds best to inhaled nitric oxide as a selective pulmonary vasodilator. Dobutamine and milrinone may help inotropy but not selectively reduce PVR; norepinephrine and vasopressin are systemic vasopressors without pulmonary specificity.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "The clinical presentation describes a patient with acute right ventricular (RV) failure post-cardiopulmonary bypass, characterized by refractory hypotension, RV dilation, septal shift (impairing left ventricular filling), and elevated pulmonary artery pressures. The primary pathophysiology is pressure overload of the RV due to elevated pulmonary vascular resistance (PVR).\n\nManagement generally focuses on:\n1.  Reducing RV afterload (PVR): This is crucial to improve RV ejection and correct the septal shift.\n2.  Maintaining systemic perfusion pressure: The RV is perfused during both systole and diastole (unlike the LV), but is highly dependent on the gradient between aortic pressure and RV intramural pressure. Systemic hypotension can lead to RV ischemia, worsening failure.\n3.  Improving RV contractility: Inotropes are often needed.\n\n*   Option A (Inhaled nitric oxide): This is a selective pulmonary vasodilator. It reduces PVR without causing systemic vasodilation and hypotension. By lowering RV afterload, it improves RV stroke volume and relieves the septal shift, thereby allowing better LV filling and cardiac output. Given the hypotension, this is the safest and most targeted intervention to reverse the RV failure cause.\n*   Option B (Intravenous dobutamine) and Option C (Milrinone infusion): These are \"inodilators.\" While they improve contractility and lower PVR, they also significantly lower systemic vascular resistance (SVR). In a patient with refractory hypotension, administering these agents alone can precipitate cardiovascular collapse by further dropping blood pressure and reducing RV coronary perfusion.\n*   Option D (Norepinephrine bolus): Norepinephrine is the vasopressor of choice to restore systemic blood pressure and coronary perfusion pressure in RV failure. However, it does not specifically address the elevated PVR and RV pressure overload. While necessary to support BP, the *specific* intervention to treat the described echocardiographic and catheter findings (RV dilation/high PAP) is a pulmonary vasodilator. In exam settings, identifying the selective agent for the specific pathology (PH causing RVF) is usually the key.\n*   Option E (Vasopressin drip): Similar to norepinephrine, it raises SVR. While it may have a more favorable profile regarding PVR/SVR ratio compared to catecholamines, inhaled nitric oxide is superior for lowering PVR.\n\nTherefore, the most appropriate intervention to address the high pulmonary artery pressures and RV failure without worsening hypotension is inhaled nitric oxide.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-005", "question": "A 45-year-old man with treatment-resistant depression and a history of electroconvulsive therapy presents with catatonia, mutism, and waxy flexibility. He has not responded to lorazepam. What is the most appropriate next step in management?", "options": ["Bilateral electroconvulsive therapy", "Intravenous amobarbital challenge", "High-dose olanzapine initiation", "Repetitive transcranial magnetic stimulation", "Ketamine infusion trial"], "answer": "A", "answer_index": 0, "explanation": "ECT is the treatment of choice for catatonia unresponsive to benzodiazepines, with high efficacy in psychiatric emergencies. Amobarbital is outdated and not standard; olanzapine may help but is not first-line for refractory cases. rTMS and ketamine lack strong evidence for acute catatonia.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "The clinical scenario describes a patient with catatonia (mutism, waxy flexibility) in the context of treatment-resistant depression. The first-line treatment for catatonia is benzodiazepines (e.g., lorazepam). This patient has failed to respond to lorazepam.\n\nAccording to standard treatment guidelines (e.g., Maudsley Prescribing Guidelines, APA guidelines), the definitive treatment for catatonia that is resistant to benzodiazepines is electroconvulsive therapy (ECT). ECT is highly effective for both catatonia and treatment-resistant depression. While antipsychotics (like olanzapine) are sometimes considered, they are generally avoided or used with extreme caution in the acute phase of catatonia due to the risk of worsening the condition or precipitating neuroleptic malignant syndrome. Amobarbital is primarily diagnostic. rTMS and Ketamine are not standard treatments for acute catatonia compared to ECT.\n\nTherefore, Electroconvulsive therapy is the most appropriate next step.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-006", "question": "A 65-year-old man undergoes laparoscopic cholecystectomy for acute cholecystitis. Intraoperatively, there is significant bleeding from the cystic artery that is difficult to control. Postoperative imaging reveals a pseudoaneurysm. What is the most appropriate intervention?", "options": ["Endoscopic retrograde cholangiopancreatography with stenting", "Angiographic embolization", "Surgical re-exploration with ligation", "Percutaneous transhepatic cholangiography", "Observation with serial imaging"], "answer": "B", "answer_index": 1, "explanation": "Angiographic embolization is preferred for postoperative pseudoaneurysm to minimize invasiveness and control bleeding effectively. Surgical re-exploration carries higher morbidity, ERCP addresses biliary issues not vascular, PTC is for drainage, and observation risks rupture.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "B", "model_outputs": "This clinical scenario describes a patient who developed a vascular complication (pseudoaneurysm) following a laparoscopic cholecystectomy where intraoperative bleeding occurred.\n\n1.  Diagnosis: The patient has a pseudoaneurysm, likely of the cystic artery stump or the right hepatic artery. This typically results from vascular injury during dissection or clip placement.\n2.  Pathophysiology: Pseudoaneurysms are unstable and carry a high risk of rupture, which can lead to life-threatening hemobilia (bleeding into the biliary tree), upper GI bleeding, or intraperitoneal hemorrhage. Therefore, intervention is required (ruling out Option E).\n3.  Treatment Options:\n    *   ERCP (Option A) and PTC (Option D) are procedures designed for biliary pathology (biliary leaks, retained stones, strictures), not vascular abnormalities.\n    *   Surgical re-exploration (Option C) is associated with high morbidity and mortality, particularly in the immediate postoperative period where inflammation and adhesions make dissection difficult.\n    *   Angiographic embolization (Option B) is the first-line treatment of choice. It is a minimally invasive interventional radiology procedure that precisely locates the bleeding vessel and occludes the pseudoaneurysm using coils or other embolic agents. It has a high success rate and significantly lower morbidity compared to open surgery.\n\nTherefore, angiographic embolization is the most appropriate next step.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-007", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops corneal melt and peripheral ulcerative keratitis. What is the most appropriate immunosuppressive therapy adjustment?", "options": ["Add infliximab infusion", "Switch to rituximab", "Initiate cyclophosphamide", "Topical cyclosporine", "Systemic corticosteroids with azathioprine"], "answer": "C", "answer_index": 2, "explanation": "Cyclophosphamide is used for severe ocular manifestations in rheumatoid vasculitis like corneal melt. Infliximab for joints, rituximab B-cell depletion insufficient alone, topical for surface, steroids with azathioprine less potent for melt.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "abms_specialty": "Ophthalmology", "abms_source": "target_topic", "source_label_raw": "Ophthalmology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-015", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "C", "model_outputs": "This patient with rheumatoid arthritis has developed peripheral ulcerative keratitis (PUK) with corneal melt while on methotrexate. PUK in the context of RA is a severe, sight-threatening, and potentially life-threatening complication that indicates active systemic vasculitis.\n\n1.  Severity: The presence of a corneal melt signifies a necrotizing process that requires rapid and potent immunosuppression to prevent corneal perforation and address the underlying systemic vasculitis.\n2.  Current Therapy: The patient is already on methotrexate (a DMARD), which has proven insufficient to control the disease merely by its presence, evidenced by the breakthrough of this severe complication.\n3.  Standard of Care: The historical and textbook \"gold standard\" treatment for RA-associated PUK and necrotizing scleritis is the use of systemic cytotoxic alkylating agents, most notably cyclophosphamide. While systemic corticosteroids are usually administered initially to control acute inflammation (often IV pulses), they must be combined with a cytotoxic agent to induce remission and prevent mortality associated with the systemic vasculitis. Furthermore, corticosteroids alone must be used with caution in the setting of corneal melt as they can inhibit collagen production and potentiate perforation if not covered by potent cytotoxic therapy.\n4.  Comparison of Options:\n    *   A (Infliximab) and B (Rituximab): Biologics are increasingly used in clinical practice for refractory cases or as alternatives to cyclophosphamide, but cyclophosphamide remains the definitive first-line cytotoxic choice in exam settings for sight-threatening PUK/necrotizing scleritis.\n    *   D (Topical cyclosporine): Inadequate for the systemic nature of the disease and the severity of the ocular lesion.\n    *   E (Systemic corticosteroids with azathioprine): While corticosteroids are needed, azathioprine is generally considered less potent and slower-acting than cyclophosphamide. It is typically reserved for maintenance therapy or less severe cases, making it a suboptimal choice for an active melt.\n\nTherefore, the most appropriate adjustment to halt the necrotizing process is the initiation of cyclophosphamide.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-008", "question": "A 25-year-old athlete sustains a tibial plateau fracture with associated meniscal tear and ACL disruption. Intraoperative findings include a depressed lateral plateau fragment. What is the optimal surgical approach to restore joint congruity?", "options": ["External fixation with delayed internal fixation", "Arthroscopic-assisted reduction and internal fixation", "Open reduction with bone grafting and buttress plating", "Total knee arthroplasty", "Nonoperative management with bracing"], "answer": "C", "answer_index": 2, "explanation": "Open reduction with bone grafting and buttress plating restores articular surface in complex tibial plateau fractures with depression. Arthroscopic assistance is for simpler cases, external fixation is temporary, arthroplasty is for older patients, and nonoperative risks malunion.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "abms_specialty": "Orthopedic Surgery", "abms_source": "target_topic", "source_label_raw": "Orthopedic Surgery", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "C", "model_outputs": "This patient has a displaced intra-articular fracture of the tibial plateau, specifically involving a depressed lateral plateau fragment (likely a Schatzker II or III injury), along with soft tissue injuries (meniscus and ACL).\n\n1.  Patient & Injury: A young, active patient (25-year-old athlete) requires anatomic restoration of the articular surface to minimize the risk of post-traumatic osteoarthritis and restore function.\n2.  Pathology: The key feature is the \"depressed lateral plateau fragment.\"\n3.  Mechanism of Repair:\n    *   Reduction: The depressed cartilage and subchondral bone must be elevated to restore the joint line.\n    *   Grafting: Elevation of a depressed fragment creates a metaphyseal void (defect) in the cancellous bone. This void must be filled with bone graft (autograft, allograft, or bone substitute) to provide structural support and prevent the fragment from settling (subsidence) back into a depressed position.\n    *   Fixation: A plate (often acting as a buttress for the lateral cortex or a rafting plate for the articular surface) is required to secure the reduction.\n4.  Evaluating Options:\n    *   Option C (Open reduction with bone grafting and buttress plating) accurately describes the necessary mechanical steps: reducing the fracture (often requiring a submeniscal arthrotomy to visualize the joint surface), filling the resulting void with bone graft, and applying a plate to resist shear forces and support the elevated fragments. This is the gold standard for management of depressed tibial plateau fractures.\n    *   Option A is typically reserved for high-energy injuries with severe soft tissue compromise (Schatzker V/VI) or strictly as a temporizing measure.\n    *   Option B (Arthroscopic-assisted) is a valid adjunctive technique for visualization and treating the meniscus, but Option C is the more comprehensive description of the fracture management requirements (specifically the need for grafting and plating the defects caused by depression). Without grafting, the repair is liable to fail.\n    *   Options D and E are inappropriate for a young patient with this injury pattern.\n\nThe meniscal tear is typically repaired during the open reduction. The ACL reconstruction is often performed in a delayed setting to prevent arthrofibrosis, although tibial eminence avulsions would be fixed primarily. The fracture management takes priority.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-009", "question": "In the ICU, a 55-year-old patient with septic shock on vasopressors develops acute kidney injury and metabolic acidosis. Despite fluid resuscitation, oliguria persists. Continuous renal replacement therapy is initiated. What is the most appropriate modality to optimize hemodynamic stability?", "options": ["Continuous venovenous hemodiafiltration with citrate anticoagulation", "Intermittent hemodialysis with bicarbonate buffer", "Sustained low-efficiency dialysis", "Peritoneal dialysis", "Continuous venovenous hemofiltration alone"], "answer": "A", "answer_index": 0, "explanation": "Continuous venovenous hemodiafiltration (CVVHDF) provides both convective and diffusive clearance, making it ideal for septic shock with acidosis, and citrate anticoagulation minimizes clotting while providing regional effects. Intermittent hemodialysis can cause hemodynamic instability in critically ill patients. Peritoneal dialysis is less efficient for rapid toxin removal in this setting.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Critical Care Medicine", "abms_specialty": "Critical Care Medicine", "abms_source": "topics_mapped", "source_label_raw": "critical care", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "source_question_id": "20251201T041413890Z_grok-4-0709_seed126-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed126.jsonl", "pred": "A", "model_outputs": "Here is the step-by-step reasoning to determine the correct answer:\n\n1.  Identify the Clinical Status: The patient is in septic shock, on vasopressors, and has acute kidney injury (AKI) with metabolic acidosis and oliguria. The key feature is hemodynamic instability.\n\n2.  Evaluate the Goal: The primary goal is to provide renal replacement therapy (RRT) while optimizing hemodynamic stability.\n\n3.  Compare Intermittent vs. Continuous Therapies:\n    *   Intermittent Hemodialysis (IHD) (Option B): IHD involves rapid removal of fluid and solutes over a short period (3-4 hours). This often leads to significant fluid shifts and hypotension, making it poorly tolerated by hemodynamically unstable patients on vasopressors.\n    *   Peritoneal Dialysis (Option D): While hemodynamically stable, PD is often insufficient for the rapid metabolic correction and fluid removal required in a hypercatabolic, septic patient in the ICU. It is not the standard first-line choice for acute septic shock in this context.\n    *   Continuous Renal Replacement Therapy (CRRT): CRRT involves slower, continuous removal of fluid and solutes over 24 hours. This results in greater hemodynamic stability and is the preferred modality for patients with septic shock requiring vasopressors. This leaves Options A and E.\n    *   Sustained Low-Efficiency Dialysis (SLED) (Option C): SLED is a hybrid modality that offers better stability than IHD but is generally considered an alternative to CRRT. In the context of a board exam question asking for the *most appropriate* modality for maximizing stability in severe shock, CRRT is the classic gold standard.\n\n4.  Differentiate between CRRT Options (A vs. E):\n    *   Both CVVHDF (Option A) and CVVH (Option E) are forms of CRRT and offer similar hemodynamic benefits regarding fluid removal rates.\n    *   Anticoagulation: The KDIGO Clinical Practice Guidelines for Acute Kidney Injury recommend regional citrate anticoagulation (RCA) rather than heparin in patients who do not have contraindications (like severe liver failure) for CRRT. Citrate results in longer filter life and less bleeding risk compared to systemic heparin. Maintaining circuit patency is crucial for stability because frequent clotting and restarting of circuits can lead to blood loss and transient hemodynamic deterioration.\n    *   Clearance Mechanism: CVVHDF (Continuous Venovenous Hemodiafiltration) combines diffusion (good for small molecules/acidosis correction) and convection (good for middle molecules). This allows for efficient correction of metabolic acidosis and fluid overload. CVVH (Hemofiltration) relies solely on convection. While both are effective, CVVHDF with partial diffusive clearance allows for effective solute removal with lower filtration fractions compared to pure CVVH, potentially aiding in circuit running times.\n    *   Option A explicitly includes citrate anticoagulation, aligning with best-practice guidelines for maximizing therapy delivery and minimizing complications in this patient population. Option E specifies \"hemofiltration alone,\" which is less descriptive of the optimal standard of care (which includes the anticoagulation strategy).\n\n5.  Conclusion: Continuous Venovenous Hemodiafiltration (CVVHDF) with citrate anticoagulation represents the most appropriate, guideline-supported modality to ensure effective renal support while maintaining hemodynamic stability in a patient with septic shock.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p01", "question_id": "ABMS20260101_grok-4-0709_p01-010", "question": "A 40-year-old man with epilepsy on carbamazepine develops diplopia, ataxia, and nystagmus. Serum levels are therapeutic, but free fraction is elevated. What is the most likely cause, and adjustment needed?", "options": ["Hyponatremia; restrict fluids", "Drug interaction with protein binding; reduce dose", "Autoinduction; increase dose", "Hepatic failure; switch to alternative", "Renal impairment; hemodialysis"], "answer": "B", "answer_index": 1, "explanation": "Elevated free carbamazepine due to hypoalbuminemia or displacement increases toxicity despite therapeutic total levels, requiring dose reduction. Hyponatremia causes different symptoms, autoinduction lowers levels, hepatic failure elevates total levels, renal issues don't directly affect binding.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "target_topic", "source_label_raw": "Neurology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "B", "model_outputs": "In this clinical scenario, the patient presents with classic signs of carbamazepine toxicity: diplopia (double vision), ataxia (unsteady gait), and nystagmus. The laboratory results show therapeutic total serum levels but an elevated free fraction (the percentage of drug not bound to plasma proteins).\n\n1.  Interpret the Labs and Symptoms: Carbamazepine is highly protein-bound. The pharmacological effect (and toxicity) is determined by the *free* (unbound) drug concentration. Standard assays measure *total* drug (bound + free). If the protein binding is disrupted (e.g., displacement by another drug like valproic acid, or hypoalbuminemia), the free fraction increases. This means the patient can have a much higher concentration of active drug than the total level suggests, leading to toxicity despite \"therapeutic\" total numbers.\n2.  Evaluate the Causes:\n    *   Hyponatremia (A): Carbamazepine can cause SIADH and hyponatremia. While this can cause confusion and seizures, the specific triad of diplopia, ataxia, and nystagmus, combined with the lab finding of an elevated free fraction, points to pharmacokinetic toxicity rather than electrolyte imbalance.\n    *   Drug Interaction (B): This is the classic textbook explanation for this presentation. Drugs such as valproic acid can displace carbamazepine from albumin (increasing free fraction) and/or inhibit its metabolism. This results in clinical toxicity with normal total levels due to the high unbound portion. The appropriate management for concentration-dependent toxicity is to reduce the dose.\n    *   Autoinduction (C): Carbamazepine induces its own metabolism (autoinduction), which typically lowers serum levels over time and might lead to breakthrough seizures, not toxicity with elevated free fractions. You would increase the dose, not see toxicity.\n    *   Hepatic/Renal Failure (D, E): While organ failure affects pharmacokinetics, the prompt is a classic setup for a protein-binding interaction. Furthermore, hemodialysis is not the standard management for carbamazepine toxicity (hemoperfusion is used in severe overdose, but dose adjustment is used for therapeutic toxicity), and switching drugs is not necessary if dose adjustment can fix the issue.\n\nConclusion: The patient is experiencing toxicity because the unbound (active) drug level is too high, caused by a change in protein binding (likely a drug-drug interaction). The correct management is to titrate the dose based on the patient's clinical status (symptoms) and free levels, which necessitates a dose reduction.\n\nThe answer is (B)"}]